Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells
The aim of this in vitro study was to measure the enhanced anticancer effects of Res (resveratrol) on PA (paclitaxel) in HepG2 human liver cancer cells.
Source: BMC Complementary and Alternative Medicine - Category: Complementary Medicine Authors: Qin Jiang, Manyi Yang, Zhan Qu, Jixiang Zhou and Qi Zhang Tags: Research article Source Type: research
More News: Alternative and Complementary Therapies | Cancer | Cancer & Oncology | Complementary Medicine | Liver | Study | Urology & Nephrology